KINGSLEY ALFRED D Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$226,300.44
Insider Sells Quantity
11
Insider Sells Sum
$10.93M

Insider Activity of KINGSLEY ALFRED D

Biography of KINGSLEY ALFRED D

No biography is available at this moment.

2023-06-14PurchaseInsight Molecular Diagnostics Inc.
IMDX
director
30,000
0.003%
$0.21$6,447-30.23%
2022-12-22PurchaseInsight Molecular Diagnostics Inc.
IMDX
director
25,000
0.0033%
$0.28$7,125-27.12%
2022-08-15PurchaseInsight Molecular Diagnostics Inc.
IMDX
5,000
0.0023%
$0.97$4,850-61.86%
2020-12-23SaleInsight Molecular Diagnostics Inc.
IMDX
director
900
0.0011%
$2.55$2,295+72.53%
2020-12-22SaleInsight Molecular Diagnostics Inc.
IMDX
director
7,652
0.0091%
$2.54$19,436+71.18%
2020-12-21SaleInsight Molecular Diagnostics Inc.
IMDX
director
35,148
0.0412%
$2.51$88,076+72.53%
2017-07-31SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
300,000
0.2699%
$2.80$840,000-5.93%
2016-01-20SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
600,000
0.6237%
$2.35$1.41M+20.8%
2015-11-06SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
200,000
0.2503%
$3.83$766,000-21.88%
2014-05-16SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
600,000
0.9918%
$2.45$1.47M+40.66%
2014-05-08SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
600,000
1.0374%
$2.44$1.46M+47.16%
2013-06-04SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
320,000
0.5843%
$4.16$1.33M-10.87%
2013-03-28SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
400,000
0.7796%
$3.81$1.52M0%
2012-11-15SaleLineage Cell Therapeutics, Inc.
LCTX
See Remarks
689,656
1.3683%
$2.90$2M+31.48%
2006-08-22PurchaseLineage Cell Therapeutics, Inc.
LCTX
179,024
0.8348%
$0.20$35,805+136.84%
2006-06-26PurchaseLineage Cell Therapeutics, Inc.
LCTX
103,072
0.4568%
$0.24$24,737+54.17%
2006-06-23PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
1,150
0.0051%
$0.24$276+47.92%
2006-06-22PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
72
0.0003%
$0.24$17+45.83%
2006-06-20PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
45
0.0002%
$0.24$11+41.67%
2006-06-15PurchaseLineage Cell Therapeutics, Inc.
LCTX
11,000
0.0488%
$0.24$2,640+29.17%
Total: 27
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.